Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Ani Pharmaceuticals Inc (ANIP)

275 + Investors. Track Smart Money conviction in ANIP. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -5
Streak
1Q ▼
Buyers last Q
54%

Smart Money Signals — ANIP

Based on 276 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their ANIP positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (98% of max)

98% of all-time peak
276 hedge funds hold ANIP right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +23% more funds vs a year ago

fund count last 6Q
+51 new funds entered over the past year (+23% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 54% buying

154 buying132 selling
Last quarter: 154 funds bought or added vs 132 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-10 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 27 → 64 → 51 → 41. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

57% of holders stayed for 2+ years

■ 57% conviction (2yr+) ■ 21% medium ■ 22% new
157 out of 276 hedge funds have held ANIP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
➡️

Steady discovery — ~41 new funds/quarter

49 → 27 → 64 → 51 → 41 new funds/Q
New funds entering each quarter: 27 → 64 → 51 → 41. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 61% of holders stayed 2+ years

■ 61% veterans ■ 13% 1-2yr ■ 26% new
Of 282 current holders: 171 (61%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 32% AUM from major funds

32% from top-100 AUM funds
49 of 276 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.8
out of 10
Low Exit Risk
Exit risk score 3.8/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ANIP

In 2026 Q1, 154 hedge funds were net buyers of ANIP (41 opened a new position, 113 added to an existing one), while 132 reduced or exited (86 trimmed, 46 sold completely) — a 54% buyer ratio, indicating a slight buying edge. 32% of total institutional value in ANIP is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -5 funds (more exits than new entries). Total institutional holders: 276.

Hedge Fund Ownership: ANIP

How many hedge funds hold ANIP — quarterly history vs. share price
Quarterly hedge fund ownership of ANIP vs. share price

Market Analysis: ANIP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ANIP

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Ani Pharmaceuticals Inc (ANIP) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ANIP has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 76d ago
ANIP
+6.2%
XLV
+4.9%

ANIP outperformed XLV by +1.3% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 31d ago
ANIP
+4.7%
XLV
+6.0%

Since the filing became public, ANIP outperformed XLV by -1.3% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

28 top-rated funds 2 high-conviction
Consensus
6.3
/ 10
breadth
×
Elite
3.0
/ 10
conviction
Hedge Fund Positioning: ANIP
275 + Investors

Track Smart Money conviction in ANIP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 275 281 -2.14%
13F Shares 24M 22M 10.16%
Total Value $1.80B $1.70B 5.82%
New Positions 40 51 -11
Increased Positions 113 112 +1
Closed Positions 46 36 +10
Reduced Positions 83 75 +8
Total Calls 4 5 -20.0%
Total Puts 3 4 -25.0%
PUT/CALL Ratio 0.75 0.8 Neutral

Statistics: ANIP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

275 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ANIP. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ANIP holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Jones Hill Capital LP 5.25% 318,591 $24.5M
2 Goldentree Asset Management LP 3.04% 667,981 $51.3M
3 Sio Capital Management, LLC 2.93% 265,543 $20.4M
4 Tang Capital Management LLC 2.76% 707,500 $54.4M
5 Soleus Capital Management, L.P. 2.55% 820,243 $63.1M
6 Parkman Healthcare Partners LLC 2.23% 280,575 $21.6M
7 Ranger Investment Management, L.P. 2.00% 360,083 $27.7M
8 Global Alpha Capital Management Ltd. 1.67% 361,240 $27.8M
9 Marathon Capital Management 1.25% 72,590 $5.6M
10 Penn Capital Management Company, LLC 1.07% 179,716 $13.8M
11 Globeflex Capital L P 0.98% 84,145 $6.5M
12 Ikarian Capital, LLC 0.94% 150,000 $11.5M
13 Ikarian Capital, LLC 0.92% 147,085 $11.3M
14 Hussman Strategic Advisors, INC. 0.87% 52,500 $4.0M
15 Deep Track Capital, LP 0.75% 600,000 $46.1M
16 Mitsubishi UFJ Asset Management (UK) Ltd. 0.72% 18,000 $1.4M
17 Perkins Capital Management Inc 0.57% 7,841 $603K
18 Oberweis Asset Management Inc/ 0.50% 221,386 $17.0M
19 Virtus Advisers, LLC 0.48% 13,556 $1.0M
20 Kennedy Capital Management LLC 0.48% 293,996 $22.6M
21 Emerald Investment Advisers, LLC 0.46% 66,012 $5.1M
22 Mizuho Markets Americas LLC 0.44% 210,768 $16.2M
23 Oliver Luxxe Assets LLC 0.36% 31,520 $2.4M
24 Wakefield Asset Management LLLP 0.29% 14,078 $1.1M
25 Diametric Capital, LP 0.24% 11,840 $910K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Ani Pharmaceuticals Inc (ANIP)

What does the Smart Money Trend signal show for ANIP?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their ANIP positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for ANIP?

Slight buying edge — 54% buying: Last quarter: 154 funds bought or added vs 132 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ANIP holders?

Strong quality — 32% AUM from major funds: 49 of 276 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ANIP?

57% of holders stayed for 2+ years: 157 out of 276 hedge funds have held ANIP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Ani Pharmaceuticals Inc (ANIP) following the 2026 Q1 hedge fund 13F filings?

As of today, ANIP has moved +4.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -1.3%. Since the quarter end (March 31, 2026), ANIP has gained +6.2% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →